Moreover, Cortactin (CTTN) – another relevant intermediate molecule of the actin cytoskeleton machinery which is overexpressed in CLL patients [30] – also promotes CLL cell migration towards CXCL12, and was described as a major mediator of NEDD9-driven migration [31]. This evidence concerns the gene NEDD9 and B-cell chronic lymphocytic leukemia.